CAREMAPS Ai
Smarter embryo selection powered by AI and expert care.
A new standard in embryo assessment
Choosing the right embryo is one of the most important parts of IVF. Caremaps Ai helps us do that with greater clarity, consistency, and confidence.
Developed by Care Fertility scientists and trained on over 60,000 embryo journeys, Caremaps Ai uses artificial intelligence to analyse how embryos develop over time. It ranks each one by its potential to result in a live birth — supporting our embryologists in selecting the embryo with the best chance of success.
It's just one of the ways we’re combining leading science with compassionate care, to give you the very best chance of having a baby.
What is Caremaps Ai?
Caremaps Ai is a pioneering embryo selection tool, built in-house by Care Fertility scientists. Using nearly half a billion time-lapse images captured during embryo development, it analyses each embryo and ranks them from 1 to 10 based on their potential to implant and lead to a live birth.
This allows our embryologists to make a more informed decision when selecting an embryo for transfer — supported by data, not just appearance.
Caremaps Ai doesn’t replace human expertise. It works alongside our embryology team, offering a second expert opinion that’s fast, unbiased, and backed by science.
Caremaps Ai is the most advanced embryo assessment tool we’ve ever developed. It combines over a decade of research, thousands of embryo journeys, and leading AI technology — all designed to help give our patients the best possible chance of success.
What is time-lapse incubation?
Time-lapse incubation uses a specialist device called the EmbryoScope™. This incubator has a built-in camera that photographs each embryo every 10 minutes — collecting over 5,000 images across its early development.
These images are stitched into a time-lapse video, showing every moment from fertilisation through to the blastocyst stage. This continuous monitoring happens in a stable, undisturbed environment — giving us clearer insights without compromising embryo development.
Why embryo selection matters
Not all embryos that reach the blastocyst stage are genetically normal. Even those with chromosomal abnormalities can appear healthy under the microscope.
That’s why selecting the right embryo is so crucial — and why Caremaps Ai can make a difference. It identifies differences that aren’t always visible to the human eye, helping us prioritise the embryo with the highest potential for a successful pregnancy.
Caremaps Ai doesn’t change your embryos. It simply helps us identify the one with the best chance of success, so we can prioritise it for transfer.
What makes Caremaps Ai different?
Is Caremaps Ai effective?
Yes. Our research shows that Caremaps Ai improves embryo selection compared to traditional methods alone — particularly when patients have multiple embryos to choose from.
It’s already been used to support tens of thousands of IVF cycles across our clinics. The data it provides helps our embryologists make decisions with greater confidence, and many patients tell us it gives them peace of mind during a highly emotional time.
How much does Caremaps Ai cost?
Caremaps Ai is available at all Care Fertility clinics for £995.
This includes:
- Time-lapse culture using the EmbryoScope™
- AI-led embryo ranking and selection support
- A personal embryo video, available via your Salve app
If you’d like to add Caremaps Ai to your IVF treatment, please speak to your specialist or contact our Patient Services Team.
Awards and recognition
- Caremaps Ai is an award-winning technology, developed entirely in-house at Care Fertility.
- Our findings have been published in leading scientific journals, including Fertility and Sterility and Human Reproduction.
- Caremaps Ai has contributed to real-world success for thousands of patients across the UK.
We're proud to be leaders in this field — always looking for ways to improve outcomes and give our patients the very best care


.jpg?width=300&name=National-technology-awards-logo%20(1).jpg)
Awards and recognition
- Caremaps Ai is an award-winning technology, developed entirely in-house at Care Fertility.
- Our findings have been published in leading scientific journals, including Fertility and Sterility and Human Reproduction.
- Caremaps Ai has contributed to real-world success for thousands of patients across the UK.
We're proud to be leaders in this field — always looking for ways to improve outcomes and give our patients the very best care


.jpg?width=300&name=National-technology-awards-logo%20(1).jpg)
Human Fertilisation and Embryology Authority (HFEA) rating
The Human Fertilisation and Embryology Authority (HFEA) lists time-lapse imaging — the technology behind Caremaps Ai — as an optional treatment add-on. While it’s not currently rated ‘green’, the HFEA acknowledges that time-lapse monitoring may offer benefits for some patients.
We believe that when used alongside expert clinical judgment, Caremaps Ai can provide valuable additional insight — helping support personalised, well-informed decisions.
For more on how the HFEA evaluates treatment add-ons, you can visit their official guidance.